CHEMOTHERAPY Fig. 1 Body weight changes of pregnant mice treated orally with AM- 715 Day of sestation

Similar documents


CHEMOTHERAPY

CHEMOTHERAPY NOV. 1990

VOL. 34 S-2 CHEMOTHERAPY

CHEMOTHERAPY APR. 1984

CHEMOTHERAPY DEC.1992

A Nutritional Study of Anemia in Pregnancy Hematologic Characteristics in Pregnancy (Part 1) Keizo Shiraki, Fumiko Hisaoka Department of Nutrition, Sc


VOL.40 S-1

Fig. 2 Body weight curves rats treated orally with DL-8280 for 4 weeks

2 94

VOL. 34 S-2 CHEMOTH8RAPY 913

CHEMOTHERAPY Fig. 1 Chemical structure of TE-031


VOL.39 S-3

Table1MIC of BAY o 9867 against standard strains

CHEMOTHERAPY Table 1 Urinary excretion of mezlocillin Fig. 4 Urinary excretion of mezlocillin Fig. 3 Blood levels of mezlocillin

Fig.1 Chemical structure of BAY o 9867

Experimental and Clinical Studies of Pregnant Hypertension Takashi SHIMAZU Department of Obstetrics and Gynecology, Osaka City University Medical Scho

Jan THE JAPANESE JOURNAL OF ANTIBIOTICS XL-1 Table 1. Outline of administering doses, routes and sampling times *: 4 ml/hr/kg Bacillus subtilis

Visual Evaluation of Polka-dot Patterns Yoojin LEE and Nobuko NARUSE * Granduate School of Bunka Women's University, and * Faculty of Fashion Science,

Clostridium difficile ciprofloxacin, ofloxacin, norfloxacin Bifidobacterium Lactobacillus Lactobacillus Bacteroides fragilis B. fragilis C. difficile


udc-2.dvi

The Effect of the Circumferential Temperature Change on the Change in the Strain Energy of Carbon Steel during the Rotatory Bending Fatigue Test by Ch

国土技術政策総合研究所　研究資料

Fig. 1 Chemical structure of DL-8280



CHEMOTHERAPY aureus 0.10, Enterococcus faecalis 3.13, Escherichia coli 0.20, Klebsiella pneumoniae, Enterobacter spp., Serratia marcescens 0.78, Prote

VOL. 36 S-3 CHEMOTHERAPY 437


Fig.2. Sensitivity distribution of clinical isolates of S. epidermidis (24 strains, 106 CFU/ml) Staphylococcus aureus Staphylococcus epider- midis Ent

Table 1 Components of corn dietary fibers


Fig. 1 Chemical structure of TE-031 Code number: TE-031 Chemical name: (-) (3R, 4S, 5S, 6R, 7R, 9R, 11R, 12R, 13S, 14R)-4-[(2, 6-dideoxy-3-C-methyl-3-

Changes in Electrodermal Activity Associated with Candies and Chewing Gum Chewing Satoshi Beppu, Takeshi Morita*, Susumu Igarashi **, Kanichi Seto* an

THE JAPANESE JOURNAL OF PERSONALITY 2007, Vol. 15 No. 2, 217–227

Rubin Rubin

Table 1. Antibacterial activitiy of grepafloxacin and other antibiotics against clinical isolates


VOL.42 S-1

Key words : 7432-S, Oral cephem, Urinary tract infection Fig. 1. Chemical structure of 7432-S.

CHEMOTHERAPY JUN Citrobacter freundii 27, Enterobacter aerogenes 26, Enterobacter cloacae 27, Proteus rettgeri 7, Proteus inconstans 20, Proteus

Fig. 1 A: Effects of intramuscular injection of glucagon on the blood glucose levels (changes from basal, ƒ BG) as compared with effects of scopolamin

Table 1. Influence of food deprivation on gastric secretion and severity of ulceration in 18 hr pylorus ligated rats.



スポーツ選手における日常的ﾄﾚｰﾆﾝｸﾞが味覚に及ぼす影響について

CHEMOTHERAPY MAY. 1988

1272 CHEMOTHERAPY MAR. 1975

106(18) 原 使 用 した 測 定 部 位 は 期 門 穴相 当部 位 の 表 皮 上 及 び 真 皮 下 と し, 表 皮上 で は 艾 柱 の 直 下 に 熱 電 対 先 端 を露 出 し固 定 した 真 皮 下 で は施 灸部 より10mm 下 方 を切 開 剥 離 し, 施 灸 部 直

VOL. 19 NO. 5 CHEMOTHERAPY

CHEMOTHERAPY APR Fig. 1 Chemical structure of cefotetan (CTT, YM09330)

988 CHEMOTHERAPY NOV. 1971

The Phase Behavior of Monooleoylglycerol-Water Systems Mivoshi Oil & Fat Co.. Ltd. Faculty of Science and Technology, Science University of Tokyo Inst

Effects of Isomaltooligosaccharides Intake on Defecation and Intestinal Environment in Healthy Volunteers Toshiyuki KANEKO, Takanobu KOHMOTO, Hiroe KI


CHEMOTHERAPY

VOL. 20 NO. 5 CHEMOTHERAPY Methoxy-4-sulfanilamidopyrimidine (OS-3376) Sulfadimethoxine (SDM) Table 1. In vitro antibacterial activities of OS-3

CHEMOTHERAPY DEC Table 1 Antibacterial spectra of T-1982, CTT, CMZ, CTX, CPZ and CEZ 106 CFU/ml Note: P; Peptococcus, S; Streptococcus, G; Gaffk

パーソナリティ研究 2005 第13巻　第2号　170–182

Key words: E. coli O 157: H7, fosfomycin, verotoxin, mouse infection

日本消化器外科学会雑誌第25巻第11号

2001 Received November 28, 2014 Current status and long-term changes of the physique and physical fitness of female university students Shiho Hiraku Y

Effects of Light and Soil Moisture Condition on the Growth of Seedlings for Quercus serrata and Quercus variabilis NISHIMURA, Naoyuki*, OTA, Takeshi**

(43) Vol.33, No.6(1977) T-239 MUTUAL DIFFUSION AND CHANGE OF THE FINE STRUCTURE OF WET SPUN ANTI-PILLING ACRYLIC FIBER DURING COAGULATION, DRAWING AND

474 Nippon Shokuhin Kagaku Kogaku Kaishi Vol. /-, No.3,.1..2* (,**0) 24 Measurement of Deterioration of Frying Oil Using Electrical Properties Yoshio

Q [4] 2. [3] [5] ϵ- Q Q CO CO [4] Q Q [1] i = X ln n i + C (1) n i i n n i i i n i = n X i i C exploration exploitation [4] Q Q Q ϵ 1 ϵ 3. [3] [5] [4]


Studies of Foot Form for Footwear Design (Part 9) : Characteristics of the Foot Form of Young and Elder Women Based on their Sizes of Ball Joint Girth

<95DB8C9288E397C389C88A E696E6462>

Title 外傷性脊髄損傷患者の泌尿器科学的研究第 3 報 : 上部尿路のレ線学的研究並びに腎機能について Author(s) 伊藤, 順勉 Citation 泌尿器科紀要 (1965), 11(4): Issue Date URL

( ) [1] [4] ( ) 2. [5] [6] Piano Tutor[7] [1], [2], [8], [9] Radiobaton[10] Two Finger Piano[11] Coloring-in Piano[12] ism[13] MIDI MIDI 1 Fig. 1 Syst

CHEMOTHERAPY JUNE 1986

Dec. THE JAPANESE JOURNAL OF ANTIBIOTICS XXXVII (45)

名称未設定-1



DAY )

STUDIES ON THE PHYSICAL FITNESS OF SUMO WRESTLERS (REPORT II) (PHYSICAL FITNESS AND DEVELOPMENT OF THE SEKITORI) SHINKICHI OGAWA, YOSHINORI FURUTA, KE

ec6

報告書 H22-2A-09

CHEMOTHERAPY Fig. 1 Chemical structure of CXM-AX

CHEMOTHERAPY NOV S. aureus, S. epidermidis, E. coli, K. pgeumoniae, E. cloacae, S. marcescens, P. mirabilis, Proteus, P. aeruginosa Inoculum siz


浜松医科大学紀要

Physical and Psychological Effects of Stressors in Female College Students Reizou Mita*1, Konosuke Tomabechi*1, Isao Yamaguchi*1, Naoko Soeno*1, Shuhe

THE JAPANESE JOURNAL OF ANTIBIOTICS 65 6 Dec LVFX 100 mg 3 / mg 2 / LVFX PK PD mg mg 1 1 AUC/MIC

43 + +* / +3+0,, 22*,, ++..0/ / 1/. / / + /* *,* +* *.* /* *,/./ +3+,. + : / 3 / +** +**, // /. /+ /+ + * * ,* , 0.. /3 : +/,.

VOL.35 S-2 CHEMOTHERAPY Table 1 Sex and age distribution Table 2 Applications of treatment with carumonam Table 3 Concentration of carumonam in human

Therapy for Asthenopia in Cases of Convergence Insufficiency Hiroko TAKASAKI, C.O.J., Nobuko INAGAMI, C.O.J., and Kayoko TAKENAWA, C.O.J.. Orthoptic c

Table 1 Characteristics of the study participants in Imari municipal hospital

<4D F736F F D2094AD92428CA48B CB B4C92C789C1816A462E646F63>

Time Variation of Earthquake Volume and Energy-Density with Special Reference to Tohnankai and Mikawa Earthquake Akira IKAMi and Kumizi IIDA Departmen

本文.indd

I

J. Soc. Cosmet. Chem. Jpn. 7-chome, Edogawa-ku, Tokyo 132, Japan 2.1 J. Soc. Cosmet. Chem. Japan. Vol. 31, No

日本化学療法学会雑誌第51巻第2号

Transcription:

CHEMOTHERAPY

CHEMOTHERAPY Fig. 1 Body weight changes of pregnant mice treated orally with AM- 715 Day of sestation

CHEMOTHERAPY Table 1 Preliminaly test of AM- 715 1): Mean } SD *: Significant difference from control (p< 0.05)

CHEMOTHERAPY Fig. 2 Body weight changes of pregnant mice treated orally with AM- 715 Day of gestation

CHEMOTHERAPY Fig. 3 Food and water consumption changes of pregnant mice treated orally with AM- 715 Food consumption Day of gestation Water consumption Day of gestation

CHEMOTHERAPY Table 2 Effects of AM- 715 on the mouse fetuses 1): Mean } SD 2): No. of malformation/ @ No. of examined fetus *: Significant difference from control (p< 0.0.5)

CHEMOTHERAPY Table 3 Effects of AM- 715 on the skeleton of mouse fetuses 1): Mean } SD Each value of parentheses was expressed as percentage. Significant difference from control (p< 0.05)

CHEMOTHERAPY Table 4 Effects of AM- 715 on delivery and postnatal development of F1 mice 1): Mean } SD *: Significant difference from control (p< 0.05)

CHEMOTHERAPY Table 5 Effects of AM- 715 on growth, sexual function and functional tests of F1 mice

CHEMOTHERAPY DEC. 1981 Table 6 Effects of AM- 715 on organ weights of F1 mice at 4- week old Organ weights were expressed as ~10 mg unit *: Significant difference from control (p<0.05)

VOL.29 S-4 CHEMOTHERAPY Table 7 Effects, of AM- 715 on skeleton of F1 mice at 4- week old Each value of parentheses was expressed as percentage Significant difference from control (p< 0.05)

CHEMOTHERAPY DEC. 1981 Table 8 Effects of AM- 715 on body weight changes of F1 mice Body weights were expressed as gram unit Significant difference from control (p< 0.05)

VOL.29 S-4 CHEMOTHERAPY Table 9 Effects of AM- 715 on open field behavior in F1 mice Significant difference from control (p< 0.05) Table 10 Effects of AM- 715 on learning behavior by LASHLEY III type maze in F1 mice

CHEMOTHERAPY DEC. 1981 Table 11 Effects of AM- 715 on reproductive performance of F1 mice 1) WILSON, J. G.: Method for administering agents and detecting malformations in experimental animals. In Teratology, Principles and Techniques. J. G. WILSON& J. WARICANY, Eds., The University of Chicago Press, pp.262 `277, 1965 2) BARROW, M. V.& W. J. TAYLOR: A rapid method for detecting malformations in rat fetuses. J. Morphol. 127: 291 `306, 1969 3) DAWSON, A. B.: A note on the staining of the skeleton of cleared speciments with alizarine red S. Stain. Technol. 1: 123 `124, 1926

VOL. 29 S-4 CHEMCITHERAPY Table 12 Effects of AM- 715 on delivery and postnatal development of F1 mice *: Significant difference from control (p< 0.05)

CHEMOTHERAPY DEC. 1981 Table 13 Effects of AM- 715 on growth, sexual function and functional tests of F2 mice

VOL.29 S-4 CHEMOTHERAPY Table 14 Effects of AM- 715 on organ weights of F2 mice at 4- week old Organ weights were expressed as ~10 mg unit *: Significant difference from control (p< 0.05)

CHEMOTHERAPY DEC. 1981 Table 15 Effects of AM- 715 on skeleton of F2 mice at 4- week old Each value of parentheses was expressed as percentage *: Significant difference from control (p< 0.05) Table 16 Effects of AM- 715 on body weight changes of F2 mice Body weights were expressed as gram unit *: Significant difference from control (p< 0.05)

VOL.29 S-4 CHEMOTHERAPY Table 17 Effects of AM- 715 on Open field behavior in F2 mice * Significant difference from control (p< 0.05) Table 18 Effects of AM- 715 on learning behavior by LASHLEY Ill type maze in F2 mice *: Significant difference from control (p< 0.05)

CHEMOTHERAPY DEC. 1981 Table 19 Effects of AM- 715 on reproductive performance of F2 mice REPRODUCTION STUDIES OF AM- 715 IN MICE II. TERATOLOGICAL STUDY TSUTOMU IRIKURA, HIROSHI SUZUKI and TSUTOMU SUGIMOTO Central Research Laboratories, Kyorin Pharmaceutical Co., Ltd. Teratological study of AM- 715, a new synthetic antibacterial agent, was carried out in mice. AM- 715 was orally administered at daily doses of 125, 250 and 500mg/ kg for 10 days from the day 6 to day 15 of pregnancy. The effects of AM- 715 on dams, fetal teratogenicity and development, and also on the postnatal development of newborm mice (F1 and F2) were studied. No untoward effects on dams were found in all the dose groups during the period of administration. No lethal effects of AM- 715 on fetuses were observed in all the dose groups. Some of external and skeletal abnormalities were observed in the control group and the dose groups, but neither statistical difference as compared with the control group nor dose-dependent relationship was found in these findings. In the newborn mice of F1 and F2 generations, no abnormalities were observed in functional tests and behavior observation, and no untoward effects on reproductive performance were found. It is conclubed from the present study that AM- 715 has no teratogenic effects in mice.

2024 © docsplayer.net プライバシー | 利用規約 | フィードバック